Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

The Effects of Anabolic Steroids and Protease Inhibitors on People Living With HIV/AIDS

This study has been completed.
Sponsor:
Collaborator:
Ontario Ministry of Health and Long Term Care
Information provided by (Responsible Party):
Dr. Wendy Wobeser, Queen's University
ClinicalTrials.gov Identifier:
NCT00202241
First received: September 13, 2005
Last updated: January 12, 2016
Last verified: January 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Estimated Study Completion Date: June 2001
  Estimated Primary Completion Date: No date given